Marcos Cortes

Whatsapp Instagram Linkedin X-twitter

OI

I'm Marcos
Cortes

 
 
 
 

I, Marcos Cortes, am recognized as an accomplished M&A specialist within the Industrial and Life Sciences sectors.

Boasting nearly three decades of consulting experience since 1992, I am a proud and valuable member of the exceptional team at Alvarez & Marsal (A&M) Corporate Transactions Group (CTG).

In my role, I manage a spectrum of initiatives related to mergers, acquisitions, and carve-outs, overseeing the entire lifecycle from due diligence to post-closing activities. And before my tenure at A&M, I was part of the KPMG M&A Strategy team.

 

What we can do for you

 

Integrated Due Diligence: FDD, Tax, Operations, Human Capital, IT, etc.

Value Capture & Optimization: Interim Leadership, IPO Readiness, Financial & Tax Performance and Business Optimization

Transaction Planning & Execution: Functional Planning & Execution, Cultural Integration, Operating Model Design, Synergy Analysis & Planning

M&A Strategy: Restructuring Enterprise Portfolios, Lifecycle Performance Improvement and M&A Tax Strategy

 

Professional and Industry Experience

Led the $63B integration of a Fortune 100

Global Pharma company, enhancing their market presence in aesthetics, eye care, CNS, and gastroenterology.

Led the successful divestment of the industrial power division,

resulting in a standalone business unit and the creation of a Joint Venture poised to lead in industrial gas turbine innovation.

Directed a $4B divestiture

of a business unit for a Fortune 500 technology multinational based in California, overseeing finance, accounting, HR, and IT functions.

Orchestrated strategic due diligence

for a market-leading diabetes and obesity biopharma, acquiring a biopharmaceutical company’s manufacturing arm and integrating 400 specialists to elevate oral drug production and innovation.

Led the integration of the University of Florida

(UF) and the Scripps Research Florida Institute, ensuring a successful deal closure and smooth transition.

Performed detailed synergy and cost assessment

for a leading private investment firm, contributing to the formation of the largest pediatric home healthcare company in the U.S. (transaction size $1.3B).

Advised a $1B complex divestment

for a large multinational pharmaceutical company, facilitating the separation planning and execution of a U.S. based dermatology and generic oral solids portfolio.

Advised on the $31B Tax-Free Spin

of the Medical Device division from a global Pharmaceutical Company, a pivotal move in the company’s strategic realignment.

Conceptualized the development of a Balance Sheet Depletion methodology

during a $1B US based manufacturing carve-out, leveraging financial report expertise

Led a complex carve-out and $300M transition of Gross-to-Net Liabilities

establishment of a temporary selling agency model and working capital strategy to facilitate business transition to the buyer

Facilitated the Legal Entity integration plan

of a Global manufacturing portfolio in +150 countries, streamlining operations and enhancing market agility.

Pioneered an innovative technology accelerator

a cutting-edge instrument designed to guide M&A execution projects through the intricacies of the modern value-creation deal landscape.

Education, Licenses, & Certifications

MBA, Entrepreneurship Concentration, Rollins College (Crummer Business School)

Advanced M&A Strategy Program, UCLA

MS Pharmaceutical Sciences w/ concentration in
Pharmaceutical Regulation specialty track, UF (candidate)

Pharmaceutical Management, Cornell University

BS, Engineering, Universidade Cruzeiro do Sul

Certified Project Management Professional (PMP)

 

A&M AWARDS

Vault Consulting Survey 2024 - Top Consulting Firm Globally

A&M is proud to be ranked as a Top Consulting Firm in APAC, EMEA and North America. North America is ranked #3 in the Top 50 Consulting Firms for the region, EMEA is ranked #7 in the Top 25 Consulting Firms in the region, and APAC is ranked #5 in the Top 20 Consulting Firms in the region.

Private Equity Wire European Awards 2024 - Best Deal Advisory Firm

A&M is proud to have won Best Deal Advisory Firm at the Private Equity Wire European Awards 2024.

let’s talk!